Correlation Between Apellis Pharmaceuticals and Puma Biotechnology
Can any of the company-specific risk be diversified away by investing in both Apellis Pharmaceuticals and Puma Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Apellis Pharmaceuticals and Puma Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Apellis Pharmaceuticals and Puma Biotechnology, you can compare the effects of market volatilities on Apellis Pharmaceuticals and Puma Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Apellis Pharmaceuticals with a short position of Puma Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Apellis Pharmaceuticals and Puma Biotechnology.
Diversification Opportunities for Apellis Pharmaceuticals and Puma Biotechnology
0.04 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Apellis and Puma is 0.04. Overlapping area represents the amount of risk that can be diversified away by holding Apellis Pharmaceuticals and Puma Biotechnology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Puma Biotechnology and Apellis Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Apellis Pharmaceuticals are associated (or correlated) with Puma Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Puma Biotechnology has no effect on the direction of Apellis Pharmaceuticals i.e., Apellis Pharmaceuticals and Puma Biotechnology go up and down completely randomly.
Pair Corralation between Apellis Pharmaceuticals and Puma Biotechnology
Given the investment horizon of 90 days Apellis Pharmaceuticals is expected to generate 0.74 times more return on investment than Puma Biotechnology. However, Apellis Pharmaceuticals is 1.36 times less risky than Puma Biotechnology. It trades about 0.18 of its potential returns per unit of risk. Puma Biotechnology is currently generating about 0.02 per unit of risk. If you would invest 2,825 in Apellis Pharmaceuticals on September 14, 2024 and sell it today you would earn a total of 449.00 from holding Apellis Pharmaceuticals or generate 15.89% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Apellis Pharmaceuticals vs. Puma Biotechnology
Performance |
| Timeline |
| Apellis Pharmaceuticals |
| Puma Biotechnology |
Apellis Pharmaceuticals and Puma Biotechnology Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Apellis Pharmaceuticals and Puma Biotechnology
The main advantage of trading using opposite Apellis Pharmaceuticals and Puma Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Apellis Pharmaceuticals position performs unexpectedly, Puma Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Puma Biotechnology will offset losses from the drop in Puma Biotechnology's long position.| Apellis Pharmaceuticals vs. Puma Biotechnology | Apellis Pharmaceuticals vs. Iovance Biotherapeutics | Apellis Pharmaceuticals vs. Day One Biopharmaceuticals | Apellis Pharmaceuticals vs. Inozyme Pharma |
| Puma Biotechnology vs. Ultragenyx | Puma Biotechnology vs. Crinetics Pharmaceuticals | Puma Biotechnology vs. Arvinas | Puma Biotechnology vs. Revolution Medicines |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Other Complementary Tools
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |